IRIS PubliCatt

Cassano, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.171
EU - Europa 3.162
AS - Asia 481
AF - Africa 35
OC - Oceania 5
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.862
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.164
DE - Germania 1.315
SE - Svezia 586
IT - Italia 303
CN - Cina 299
PL - Polonia 297
UA - Ucraina 135
IE - Irlanda 134
GB - Regno Unito 127
FR - Francia 109
IN - India 70
FI - Finlandia 57
TR - Turchia 37
CI - Costa d'Avorio 34
BE - Belgio 27
IR - Iran 23
RU - Federazione Russa 17
VN - Vietnam 14
NL - Olanda 10
SG - Singapore 9
CH - Svizzera 8
HK - Hong Kong 8
RO - Romania 8
JP - Giappone 7
CZ - Repubblica Ceca 5
KR - Corea 5
AT - Austria 4
CA - Canada 4
ES - Italia 4
LU - Lussemburgo 4
AU - Australia 3
CL - Cile 3
SA - Arabia Saudita 3
BG - Bulgaria 2
EU - Europa 2
MD - Moldavia 2
MX - Messico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
BR - Brasile 1
CM - Camerun 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
LV - Lettonia 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 6.862
Salva come PNG Salva come JPEG
Città #
Chandler 748
Warsaw 283
Ashburn 229
Fairfield 171
Dublin 133
Wilmington 121
San Mateo 116
Ann Arbor 110
Jacksonville 96
Nürnberg 91
Woodbridge 90
New York 88
Houston 84
Nanjing 83
Seattle 69
Cattolica 64
Boston 61
Cambridge 58
Princeton 53
Dearborn 52
Redmond 46
Milan 41
Marseille 40
Chicago 36
Izmir 35
Abidjan 34
Rome 33
Beijing 31
Nanchang 31
Redwood City 28
Brussels 26
Bremen 25
Lawrence 25
Falls Church 23
Helsinki 23
Leawood 19
London 18
Mountain View 18
Norwalk 18
Shanghai 18
Augusta 17
Hebei 15
Kraków 14
Los Angeles 14
Boardman 13
Dong Ket 13
Hangzhou 13
Jiaxing 11
Kish 11
Lancaster 11
Munich 10
Shenyang 10
Changsha 9
Fremont 9
Kunming 9
San Diego 9
Tianjin 9
Andover 8
Guangzhou 8
Zhengzhou 8
Simi Valley 7
Bologna 6
Busto Arsizio 6
Costa Mesa 6
Detroit 6
Hong Kong 6
University Park 6
Berlin 5
Changchun 5
Hefei 5
Lanzhou 5
Washington 5
Zurich 5
Caserta 4
Phoenix 4
Prague 4
Sacramento 4
Vienna 4
Florence 3
Gunzenhausen 3
Hounslow 3
Jinan 3
Lanzo d'Intelvi 3
Mumbai 3
Ningbo 3
Northbrook 3
Paris 3
Philadelphia 3
Pune 3
Seoul 3
Zanjan 3
Alexandria 2
Amsterdam 2
Ardabil 2
Auckland 2
Benevento 2
Bern 2
Birmingham 2
Burlington 2
Chengdu 2
Totale 3.739
Salva come PNG Salva come JPEG
Nome #
Chance of cure following liver resection for initially unresectable colorectal metastases: analysis of actual 5-year survival 334
Liver resection for primarily unresectable colorectal metastases downsized by chemotherapy 306
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: a real- world experience 264
Pembrolizumab as first-line treatment for metastatic uveal melanoma 263
Is there a role for IGF1R and c-MET pathways in resistance to cetuximab in metastatic colorectal cancer? 241
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 200
C-myc expression is a possible keystone in the colorectal cancer resistance to egfr inhibitors 190
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 176
A retrospective multicentric observational study of trastuzumab emtansine in HER2 positive metastatic breast cancer: A real-world experience 154
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 152
Association of IL-8 and eNOS polymorphisms with clinical outcomes in bevacizumab-treated breast cancer patients: an exploratory analysis 139
[Gastrointestinal stromal tumors] 135
Thymoma in patients with MG: characteristics and long-term outcome 128
PDGFRA-mutant syndrome 126
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 123
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 122
Case of Rectal GI Stromal Tumor Demonstrating that KIT and PDGFRA Mutations Are Not Always Mutually Exclusive 122
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 120
“Triple positive” early breast cancer: an observational multicenter retrospective analysis of outcome 113
c-MYC Expression Is a Possible Keystone in the Colorectal Cancer Resistance to EGFR Inhibitors. 111
Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases 101
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 99
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 98
Are TKIs favourable for the elderly with non-small-cell lung cancer? 96
Trastuzumab-induced corneal ulceration: successful no-drug treatment of a "blind" side effect in a case report 89
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 87
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 82
Is surgery mandatory in locally advanced gastrointestinal stromal tumors after imatinib? A case report and literature review. 81
[Gastrointestinal stromal tumors] 79
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): A randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX 79
Advanced colon cancer: staging and prognosis by CEA test 77
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 76
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 74
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 73
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 71
eComment. Iterative metastasectomy for recurrent pulmonary disease from colorectal cancer: A challenging issue 71
HepatoCATT Study Group for the Multidisciplinary Management of HCC. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 70
Preferential MGMT methylation could predispose a subset of KIT/PDGFRA-WT GISTs, including SDH-deficient ones, to respond to alkylating agents 66
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 65
Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis. 64
"Triple positive" early breast cancer: An observational multicenter retrospective analysis of outcome 63
ERCC1 Induction after Oxaliplatin Exposure May Depend on KRAS Mutational Status in Colorectal Cancer Cell Line: In Vitro Veritas 62
Liver metastasectomy for metastatic breast cancer patients: A single institution retrospective analysis 62
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 60
The impact of multidisciplinary team management on outcome of hepatic resection in liver-limited colorectal metastases 60
A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation 58
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 57
Divergent gastrointestinal stromal tumors in syndromic settings 56
Transradial versus Transfemoral Access for Hepatic Chemoembolization: Intrapatient Prospective Single-Center Study 56
Standardizing percutaneous Microwave Ablation in the treatment of Lung Tumors: a prospective multicenter trial (MALT study) 56
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 55
Palbociclib plus fulvestrant or everolimus plus exemestane for pretreated advanced breast cancer with lobular histotype in er+/her2− patients: A propensity score-matched analysis of a multicenter retrospective patient series 55
Interventional oncology treatment for unresecable early stage HCC in patient with high risk for intraprocedural bleeding: is a single step combined therapy safe and feasible? 54
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 53
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 53
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 52
Let‐7a‐5p, mir‐100‐5p, mir‐101‐3p, and mir‐199a‐3p hyperexpression as potential predictive biomarkers in early breast cancer patients 51
Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? 48
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 48
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 47
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives 47
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 45
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 44
Operator learning curve for transradial liver cancer embolization: Implications for the initiation of a transradial access program 44
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer 44
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 43
Percutaneous radiofrequency ablation using internally cooled wet electrodes for the treatment of patients with lung tumors 43
Poor efficacy of palbociclib in second-line treatment of metastatic lobular breast cancer in a case series: Use before or never more? 42
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 41
Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer 41
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 39
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting 38
Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study 36
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 36
Oral Health Status in Patients with Head and Neck Cancer before Radiotherapy: Baseline Description of an Observational Prospective Study 35
Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. 33
Primary cardiac synovial sarcoma: A review correlating outcomes with surgery and adjuvant therapy 32
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 30
Targeted therapy in advanced gastric carcinoma: The future is beginning 22
Triple positive breast cancer: A distinct subtype? 21
Cryoablation in Locoregional Management of Complex Unresectable Chest Neoplasms 9
Clinical outcomes of teeth adjacent to the site of mandibulotomy or mandibulectomy in patients with head and neck cancer: results from a multidisciplinary mono-institutional head and neck tumor board 4
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study) 1
Totale 6.993
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.071
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.071
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019142 0 0 0 0 0 0 0 0 0 0 88 54
2019/20201.138 152 79 81 126 86 91 126 43 63 74 150 67
2020/2021767 33 108 55 51 86 46 85 19 85 68 104 27
2021/2022927 79 45 18 107 56 38 20 144 49 59 122 190
2022/20231.900 260 265 138 331 91 221 95 185 188 37 64 25
2023/2024583 31 215 31 32 29 119 46 36 11 31 2 0
Totale 6.993